161 related articles for article (PubMed ID: 24436229)
1. Mechanism of an unusual, but clinically significant, digoxin-bupropion drug interaction.
He J; Yu Y; Prasad B; Chen X; Unadkat JD
Biopharm Drug Dispos; 2014 Jul; 35(5):253-63. PubMed ID: 24436229
[TBL] [Abstract][Full Text] [Related]
2. Isolation and characterization of a digoxin transporter and its rat homologue expressed in the kidney.
Mikkaichi T; Suzuki T; Onogawa T; Tanemoto M; Mizutamari H; Okada M; Chaki T; Masuda S; Tokui T; Eto N; Abe M; Satoh F; Unno M; Hishinuma T; Inui K; Ito S; Goto J; Abe T
Proc Natl Acad Sci U S A; 2004 Mar; 101(10):3569-74. PubMed ID: 14993604
[TBL] [Abstract][Full Text] [Related]
3. Transport of estrone 3-sulfate mediated by organic anion transporter OATP4C1: estrone 3-sulfate binds to the different recognition site for digoxin in OATP4C1.
Yamaguchi H; Sugie M; Okada M; Mikkaichi T; Toyohara T; Abe T; Goto J; Hishinuma T; Shimada M; Mano N
Drug Metab Pharmacokinet; 2010; 25(3):314-7. PubMed ID: 20610891
[TBL] [Abstract][Full Text] [Related]
4. Quantitative investigation of the impact of P-glycoprotein inhibition on drug transport across blood-brain barrier in rats.
Sugimoto H; Hirabayashi H; Kimura Y; Furuta A; Amano N; Moriwaki T
Drug Metab Dispos; 2011 Jan; 39(1):8-14. PubMed ID: 20962062
[TBL] [Abstract][Full Text] [Related]
5. Potential Drug Interactions Mediated by Renal Organic Anion Transporter OATP4C1.
Sato T; Mishima E; Mano N; Abe T; Yamaguchi H
J Pharmacol Exp Ther; 2017 Aug; 362(2):271-277. PubMed ID: 28550055
[TBL] [Abstract][Full Text] [Related]
6. Evaluation of a Potential Clinical Significant Drug-Drug Interaction between Digoxin and Bupropion in Cynomolgus Monkeys.
Shen Y; Yu Y; Lai W; Li S; Xu Z; Jin J; Yan X; Xing H; Chen X; Xiong A; Xia C; He J; Hong K
Pharm Res; 2018 Nov; 36(1):1. PubMed ID: 30402714
[TBL] [Abstract][Full Text] [Related]
7. Complex drug interactions of the HIV protease inhibitors 3: effect of simultaneous or staggered dosing of digoxin and ritonavir, nelfinavir, rifampin, or bupropion.
Kirby BJ; Collier AC; Kharasch ED; Whittington D; Thummel KE; Unadkat JD
Drug Metab Dispos; 2012 Mar; 40(3):610-6. PubMed ID: 22190694
[TBL] [Abstract][Full Text] [Related]
8. Methotrexate-bestatin interaction: involvement of P-glycoprotein and organic anion transporters in rats.
Zhu Y; Meng Q; Wang C; Liu Q; Huo X; Zhang A; Sun P; Sun H; Li H; Liu K
Int J Pharm; 2014 Apr; 465(1-2):368-77. PubMed ID: 24530518
[TBL] [Abstract][Full Text] [Related]
9. Characterization of digoxin uptake in sandwich-cultured human hepatocytes.
Kimoto E; Chupka J; Xiao Y; Bi YA; Duignan DB
Drug Metab Dispos; 2011 Jan; 39(1):47-53. PubMed ID: 20926619
[TBL] [Abstract][Full Text] [Related]
10. Transport of Bupropion and its Metabolites by the Model CHO and HEK293 Cell Lines.
Han LW; Gao C; Zhang Y; Wang J; Mao Q
Drug Metab Lett; 2019; 13(1):25-36. PubMed ID: 30488806
[TBL] [Abstract][Full Text] [Related]
11. Delineating the Role of Various Factors in Renal Disposition of Digoxin through Application of Physiologically Based Kidney Model to Renal Impairment Populations.
Scotcher D; Jones CR; Galetin A; Rostami-Hodjegan A
J Pharmacol Exp Ther; 2017 Mar; 360(3):484-495. PubMed ID: 28057840
[TBL] [Abstract][Full Text] [Related]
12. 1Alpha,25-dihydroxyvitamin D3 up-regulates P-glycoprotein via the vitamin D receptor and not farnesoid X receptor in both fxr(-/-) and fxr(+/+) mice and increased renal and brain efflux of digoxin in mice in vivo.
Chow EC; Durk MR; Cummins CL; Pang KS
J Pharmacol Exp Ther; 2011 Jun; 337(3):846-59. PubMed ID: 21421739
[TBL] [Abstract][Full Text] [Related]
13. The utility of in vitro data in making accurate predictions of human P-glycoprotein-mediated drug-drug interactions: a case study for AZD5672.
Elsby R; Gillen M; Butters C; Imisson G; Sharma P; Smith V; Surry DD
Drug Metab Dispos; 2011 Feb; 39(2):275-82. PubMed ID: 21075975
[TBL] [Abstract][Full Text] [Related]
14. Polysorbate 20 increases oral absorption of digoxin in wild-type Sprague Dawley rats, but not in mdr1a(-/-) Sprague Dawley rats.
Nielsen CU; Abdulhussein AA; Colak D; Holm R
Int J Pharm; 2016 Nov; 513(1-2):78-87. PubMed ID: 27601334
[TBL] [Abstract][Full Text] [Related]
15. Role of OATP4C1 in Renal Handling of Remdesivir and its Nucleoside Analog GS-441524: The First Approved Drug for Patients with COVID-19.
Sato T; Maekawa M; Mano N; Abe T; Yamaguchi H
J Pharm Pharm Sci; 2021; 24():227-236. PubMed ID: 34048668
[TBL] [Abstract][Full Text] [Related]
16. The digoxin-propafenone interaction: characterization of a mechanism using renal tubular cell monolayers.
Woodland C; Verjee Z; Giesbrecht E; Koren G; Ito S
J Pharmacol Exp Ther; 1997 Oct; 283(1):39-45. PubMed ID: 9336306
[TBL] [Abstract][Full Text] [Related]
17. Effect of clarithromycin on renal excretion of digoxin: interaction with P-glycoprotein.
Wakasugi H; Yano I; Ito T; Hashida T; Futami T; Nohara R; Sasayama S; Inui K
Clin Pharmacol Ther; 1998 Jul; 64(1):123-8. PubMed ID: 9695727
[TBL] [Abstract][Full Text] [Related]
18. Vectorial transport of the arginine derivatives asymmetric dimethylarginine (ADMA) and L-homoarginine by OATP4C1 and P-glycoprotein studied in double-transfected MDCK cells.
Taghikhani E; Maas R; Taudte RV; Gessner A; Fromm MF; König J
Amino Acids; 2020 Jul; 52(6-7):975-985. PubMed ID: 32642843
[TBL] [Abstract][Full Text] [Related]
19. P-glycoprotein mediated efflux in Caco-2 cell monolayers: the influence of herbals on digoxin transport.
Oga EF; Sekine S; Shitara Y; Horie T
J Ethnopharmacol; 2012 Dec; 144(3):612-7. PubMed ID: 23064285
[TBL] [Abstract][Full Text] [Related]
20. P-glycoprotein system as a determinant of drug interactions: the case of digoxin-verapamil.
Verschraagen M; Koks CH; Schellens JH; Beijnen JH
Pharmacol Res; 1999 Oct; 40(4):301-6. PubMed ID: 10527640
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
